Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 635737, 7 pages
http://dx.doi.org/10.1155/2015/635737
Review Article

Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit

1Critical Care, Hospital Pharmacy Services, Mayo Clinic, Rochester, MN 55905, USA
2Department of Pharmacy Practice, Campbell University School of Pharmacy and Health Sciences, Buies Creek, NC 27506, USA
3Department of Psychiatry & Behavioral Sciences, Duke University, Durham, NC 27710, USA
4Department of Clinical Pharmacy, University of Tennessee Medical Center, Knoxville, TN 37920, USA
5Departments of Anesthesiology and Medicine, Duke University Medical Center, Durham VAMC, Durham, NC 27710, USA
6Department of Medicine, Duke University, Durham, NC 27710, USA

Received 18 December 2014; Revised 23 April 2015; Accepted 23 April 2015

Academic Editor: Elizabeth Papathanassoglou

Copyright © 2015 S. Nelson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. T. Pun and E. W. Ely, “The importance of diagnosing and managing ICU delirium,” Chest, vol. 132, no. 2, pp. 624–636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. E. W. Ely, A. Shintani, B. Truman et al., “Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit,” The Journal of the American Medical Association, vol. 291, no. 14, pp. 1753–1762, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Ely, S. Gautam, R. Margolin et al., “The impact of delirium in the intensive care unit on hospital length of stay,” Intensive Care Medicine, vol. 27, no. 12, pp. 1892–1900, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. E. B. Milbrandt, S. Deppen, P. L. Harrison et al., “Costs associated with delirium in mechanically ventilated patients,” Critical Care Medicine, vol. 32, no. 4, pp. 955–962, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. T. D. Girard, J. C. Jackson, P. P. Pandharipande et al., “Delirium as a predictor of long-term cognitive impairment in survivors of critical illness,” Critical Care Medicine, vol. 38, no. 7, pp. 1513–1520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. N. E. Brummel and T. D. Girard, “Preventing delirium in the intensive care unit,” Critical Care Clinics, vol. 29, no. 1, pp. 51–65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Kress, A. S. Pohlman, M. F. O'Connor, and J. B. Hall, “Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1471–1477, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Barr, G. L. Fraser, K. Puntillo et al., “Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit,” Critical Care Medicine, vol. 41, no. 1, pp. 263–306, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Pandharipande, B. A. Cotton, A. Shintani et al., “Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients,” The Journal of Trauma, vol. 65, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Pandharipande, A. Shintani, J. Peterson et al., “Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients,” Anesthesiology, vol. 104, no. 1, pp. 21–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. S. K. Inouye, S. T. Bogardus Jr., P. A. Charpentier et al., “A multicomponent intervention to prevent delirium in hospitalized older patients,” The New England Journal of Medicine, vol. 340, no. 9, pp. 669–676, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Roberts, B. Haroon, and R. I. Hall, “Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm,” Drugs, vol. 72, no. 14, pp. 1881–1916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. P. P. Pandharipande, B. T. Pun, D. L. Herr et al., “Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial,” Journal of the American Medical Association, vol. 298, no. 22, pp. 2644–2653, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Shehabi, P. Grant, H. Wolfenden et al., “Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to morphine-DEXCOM study),” Anesthesiology, vol. 111, no. 5, pp. 1075–1084, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. R. Maldonado, A. Wysong, P. J. A. van der Starre, T. Block, C. Miller, and B. A. Reitz, “Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery,” Psychosomatics, vol. 50, no. 3, pp. 206–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. P. P. Pandharipande, R. D. Sanders, T. D. Girard et al., “Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial,” Critical Care, vol. 14, no. 2, article R38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. R. Riker, Y. Shehabi, P. M. Bokesch et al., “Dexmedetomidine vs midazolam for sedation of critically Ill patients: a randomized trial,” The Journal of the American Medical Association, vol. 301, no. 5, pp. 489–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. C. Reade, K. O'Sullivan, S. Bates, D. Goldsmith, W. R. S. T. J. Ainslie, and R. Bellomo, “Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial,” Critical Care, vol. 13, no. 3, article R75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Shehabi, R. R. Riker, P. M. Bokesch, W. Wisemandle, A. Shintani, and E. W. Ely, “Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients,” Critical Care Medicine, vol. 38, no. 12, pp. 2311–2318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. E. W. Ely, R. Margolin, J. Francis et al., “Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the intensive care unit (CAM-ICU),” Critical Care Medicine, vol. 29, no. 7, pp. 1370–1379, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Bergeron, M.-J. Dubois, M. Dumont, S. Dial, and Y. Skrobik, “Intensive care delirium screening checklist: evaluation of a new screening tool,” Intensive Care Medicine, vol. 27, no. 5, pp. 859–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. American Psychiatric Association and DSM-5 Task Force, Diagnostic and Statistical Manual of Mental Disorders: DSM-5, American Psychiatric Association, Washington, DC, USA, 5th edition, 2013.
  23. A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. J. W. Devlin, N. S. Al-Qadhee, and Y. Skrobik, “Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies,” Best Practice and Research: Clinical Anaesthesiology, vol. 26, no. 3, pp. 289–309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Ji, Z. Li, H. Nguyen et al., “Perioperative dexmedetomidine improves outcomes of cardiac surgery,” Circulation, vol. 127, no. 15, pp. 1576–1584, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. R. Maldonado, “Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment,” Critical Care Clinics, vol. 24, no. 4, pp. 789–856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. P. P. Pandharipande, A. Morandi, J. R. Adams et al., “Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients,” Intensive Care Medicine, vol. 35, no. 11, pp. 1886–1892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Huang, Y. Chen, A. C. H. Yu, and L. Hertz, “Dexmedetomidine-induced stimulation of glutamine oxidation in astrocytes: a possible mechanism for its neuroprotective activity,” Journal of Cerebral Blood Flow and Metabolism, vol. 20, no. 6, pp. 895–898, 2000. View at Google Scholar · View at Scopus
  29. J. Bledowski and A. Trutia, “A review of pharmacologic management and prevention strategies for delirium in the intensive care unit,” Psychosomatics, vol. 53, no. 3, pp. 203–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Hipp and E. W. Ely, “Pharmacological and nonpharmacological management of delirium in critically ill patients,” Neurotherapeutics, vol. 9, no. 1, pp. 158–175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhang, Y. Lu, M. Liu et al., “Strategies for prevention of postoperative delirium: a systematic review and meta-analysis of randomized trials,” Critical Care, vol. 17, no. 2, article R47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. A. Tan and K. M. Ho, “Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis,” Intensive Care Medicine, vol. 36, no. 6, pp. 926–939, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Y. Lin, B. He, J. Chen, and Z. N. Wang, “Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? A meta-analysis,” Critical Care, vol. 16, no. 5, article R169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Lin, J. Chen, and Z. Wang, “Meta-analysis of factors which influence delirium following cardiac surgery,” Journal of Cardiac Surgery, vol. 27, no. 4, pp. 481–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Bhana, K. L. Goa, and K. J. McClellan, “Dexmedetomidine,” Drugs, vol. 59, no. 2, pp. 263–270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. J. R. Guinter and J. L. Kristeller, “Prolonged infusions of dexmedetomidine in critically ill patients,” American Journal of Health-System Pharmacy, vol. 67, no. 15, pp. 1246–1253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. V. J. Page, E. W. Ely, S. Gates et al., “Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial,” The Lancet Respiratory Medicine, vol. 1, no. 7, pp. 515–523, 2013. View at Publisher · View at Google Scholar · View at Scopus